---
title: "BOJI CRO: \"TBA Tablets\" drug clinical trial approved"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/223195817.md"
description: "According to the Zhitong Finance APP, BOJI CRO announced that the \"TBA tablet\" developed in collaboration with Guangdong Gumaidi Health Technology Co., Ltd. has received the \"Notice of Approval for Drug Clinical Trials\" issued by the National Medical Products Administration. TBA is a new, structurally defined compound with pharmacological effects and clinical value, classified as a Category 1 innovative drug that has not been marketed domestically or internationally, with the intended indication being drug-resistant pulmonary tuberculosis"
datetime: "2024-12-24T12:29:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/223195817.md)
  - [en](https://longbridge.com/en/news/223195817.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/223195817.md)
generator: "portal-rs"
---

# BOJI CRO: "TBA Tablets" drug clinical trial approved

According to the Zhitong Finance APP, BOJI CRO (300404.SZ) announced that the "TBA tablet" developed in collaboration with Guangdong Gumaidi Health Technology Co., Ltd. has received the "Drug Clinical Trial Approval Notification" issued by the National Medical Products Administration. TBA is a new compound with a clear structure and pharmacological effects, and it has clinical value. It is a Class 1 innovative drug that has not been marketed domestically or internationally, with the intended indication being drug-resistant pulmonary tuberculosis

### Related Stocks

- [300404.CN](https://longbridge.com/en/quote/300404.CN.md)
- [600755.CN](https://longbridge.com/en/quote/600755.CN.md)
- [000952.CN](https://longbridge.com/en/quote/000952.CN.md)

## Related News & Research

- [Grand Process Technology: Strong profit growth in 1H'26, robust R&D, and rising dividends highlight ongoing expansion](https://longbridge.com/en/news/296579774.md)
- [REG - Boku Inc - Holding(s) in Company](https://longbridge.com/en/news/296599333.md)
- [German ambassador to Austria Cecere visits Rosenbauer Leonding plant](https://longbridge.com/en/news/296760366.md)
- [Innova Captab Revises FY26 Accounts and Clears Baddi Plant Expansion](https://longbridge.com/en/news/296661728.md)
- [14:29 ETBerry Street Adds SOC 2 Type II to Its Compliance Program as Payer and Enterprise Partnerships Expand](https://longbridge.com/en/news/296526272.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**